BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

759316

544578

RUBICON

img img img img
No Data Available

Rubicon Research Ltd performance

Today’s low

Today’s high

₹ 620.00 ₹ 633.95
₹ 624.30

52 week low

52 week high

₹ 570.75 ₹ 754.80
₹ 624.30

Open Price

₹ 630.85

Prev. Close

₹ 630.85

Volume (Shares)

144192.00

Total traded value

₹ 900.19

Upper Circuit

₹ 757.00

Lower Circuit

₹ 504.70

info

Rubicon Research Ltd Share Price Update

As of the latest trading session, Rubicon Research Ltd share price is currently at ₹ 622.15, which is down by ₹ -8.69 from its previous closing. Today, the stock has fluctuated between ₹ 620.00 and ₹ 633.95. Over the past year, Rubicon Research Ltd has achieved a return of [-] %. In the last month alone, the return has been -3.48 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Rubicon Research Ltd fundamentals


  • Market cap (Cr)

    10,285.40

  • P/E Ratio (TTM)

    62.05

  • Beta

    0.48

  • Book Value / share

    71.10

  • Return on equity

    27.11%

  • EPS (TTM)

    10.17

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    45.81

info icon alternate text
  • Market cap (Cr)

    10,280.40

  • P/E Ratio (TTM)

    62.05

  • Beta

    0.15

  • Book Value / share

    71.10

  • Return on equity

    27.11%

  • EPS (TTM)

    10.17

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    45.81

info icon alternate text

Rubicon Research Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 336.47
Operating Expense 276.34
Net Profit 45.81
Net Profit Margin (%) 13.61
Earnings Per Share (EPS) 2.97
EBITDA 80.62
Effective Tax Rate (%) 25.66
Particulars JUN 2025 (Values in Cr)
Revenue 278.03
Operating Expense 232.03
Net Profit 35.15
Net Profit Margin (%) 12.64
Earnings Per Share (EPS) 2.28
EBITDA 64.59
Effective Tax Rate (%) 25.88
Particulars SEP 2024 (Values in Cr)
Revenue 254.90
Operating Expense 200.19
Net Profit 42.89
Net Profit Margin (%) 16.82
Earnings Per Share (EPS) 2.82
EBITDA 71.23
Effective Tax Rate (%) 25.46
Particulars JUN 2024 (Values in Cr)
Revenue 273.27
Operating Expense 0.00
Net Profit 46.16
Net Profit Margin (%) 16.89
Earnings Per Share (EPS) 2.99
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 1073.84
Operating Expense 870.25
Net Profit 167.54
Net Profit Margin (%) 15.60
Earnings Per Share (EPS) 11.00
EBITDA 289.58
Effective Tax Rate (%) 24.96
Particulars MAR 2024 (Values in Cr)
Book Value / Share 25.31
ROE % 27.11
ROCE % 18.42
Total Debt to Total Equity 1.11
EBITDA Margin 20.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 564.84
ROE % -5.71
ROCE % 1.45
Total Debt to Total Equity 0.84
EBITDA Margin 11.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 602.36
ROE % -19.75
ROCE % -11.80
Total Debt to Total Equity 0.39
EBITDA Margin -7.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 737.96
ROE % 8.59
ROCE % 17.01
Total Debt to Total Equity 0.17
EBITDA Margin 32.35
Particulars MAR 2020 (Values in Cr)
Book Value / Share 671.60
ROE % 14.51
ROCE % 21.18
Total Debt to Total Equity 0.09
EBITDA Margin 37.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 25.31
ROE % 27.11
ROCE % 18.42
Total Debt to Total Equity 1.11
EBITDA Margin 20.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 564.84
ROE % -4.72
ROCE % 1.31
Total Debt to Total Equity 0.68
EBITDA Margin 11.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 845.39
ROE % 3.97
ROCE % 4.68
Total Debt to Total Equity 0.31
EBITDA Margin 14.36
Particulars MAR 2021 (Values in Cr)
Book Value / Share 811.56
ROE % 13.81
ROCE % 21.00
Total Debt to Total Equity 0.16
EBITDA Margin 36.86
Particulars MAR 2020 (Values in Cr)
Book Value / Share 701.08
ROE % 21.23
ROCE % 27.97
Total Debt to Total Equity 0.14
EBITDA Margin 40.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 58.39
Total Assets 1109.48
Total Liabilities 1109.48
Total Equity 385.00
Share Outstanding 152099340
Price to Book Ratio 0.00
Return on Assets (%) 8.20
Return on Capital (%) 11.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.91
Total Assets 749.70
Total Liabilities 749.70
Total Equity 286.37
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) -2.25
Return on Capital (%) -2.79
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.60
Total Assets 559.51
Total Liabilities 559.51
Total Equity 305.39
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) -11.99
Return on Capital (%) -14.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 85.98
Total Assets 538.25
Total Liabilities 538.25
Total Equity 374.14
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) 5.70
Return on Capital (%) 6.73
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 35.80
Total Assets 430.38
Total Liabilities 430.38
Total Equity 340.50
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) 11.48
Return on Capital (%) 13.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 58.39
Total Assets 1109.48
Total Liabilities 1109.48
Total Equity 385.00
Share Outstanding 152099340
Price to Book Ratio 0.00
Return on Assets (%) 8.20
Return on Capital (%) 11.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.91
Total Assets 749.70
Total Liabilities 749.70
Total Equity 286.37
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) -2.25
Return on Capital (%) -2.79
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 43.50
Total Assets 678.33
Total Liabilities 678.33
Total Equity 428.61
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) 2.45
Return on Capital (%) 2.79
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 78.64
Total Assets 569.59
Total Liabilities 569.59
Total Equity 411.46
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) 9.29
Return on Capital (%) 10.5
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 33.28
Total Assets 444.56
Total Liabilities 444.56
Total Equity 355.44
Share Outstanding 5069978
Price to Book Ratio 0.00
Return on Assets (%) 13.28
Return on Capital (%) 15.59
Particulars MAR 2024 (Values in Cr)
Net Income 102.85
Cash from Operations 39.08
Cash from Investing -68.51
Cash from Financing 43.55
Net change in Cash -3.95
Free Cash Flow 95.22
Particulars MAR 2023 (Values in Cr)
Net Income -11.04
Cash from Operations -72.92
Cash from Investing -33.82
Cash from Financing 122.81
Net change in Cash 14.24
Free Cash Flow -28.46
Particulars MAR 2022 (Values in Cr)
Net Income -66.11
Cash from Operations -54.16
Cash from Investing -54.92
Cash from Financing 63.05
Net change in Cash -54.50
Free Cash Flow 0.33
Particulars MAR 2021 (Values in Cr)
Net Income 63.12
Cash from Operations 95.11
Cash from Investing -46.09
Cash from Financing 51.50
Net change in Cash 67.08
Free Cash Flow 166.39
Particulars MAR 2020 (Values in Cr)
Net Income 74.01
Cash from Operations 32.02
Cash from Investing -84.33
Cash from Financing 80.07
Net change in Cash 1.20
Free Cash Flow 91.06
Particulars MAR 2024 (Values in Cr)
Net Income 102.85
Cash from Operations 39.08
Cash from Investing -68.51
Cash from Financing 43.55
Net change in Cash -3.95
Free Cash Flow 95.22
Particulars MAR 2023 (Values in Cr)
Net Income -11.04
Cash from Operations -72.92
Cash from Investing -33.82
Cash from Financing 122.81
Net change in Cash 14.24
Free Cash Flow -28.46
Particulars MAR 2022 (Values in Cr)
Net Income 16.92
Cash from Operations -61.51
Cash from Investing -52.21
Cash from Financing 65.22
Net change in Cash -49.07
Free Cash Flow -61.51
Particulars MAR 2021 (Values in Cr)
Net Income 85.38
Cash from Operations 81.14
Cash from Investing -31.63
Cash from Financing 52.17
Net change in Cash 70.14
Free Cash Flow 81.14
Particulars MAR 2020 (Values in Cr)
Net Income 83.68
Cash from Operations 29.61
Cash from Investing -85.47
Cash from Financing 75.91
Net change in Cash 1.02
Free Cash Flow 80.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.76 13.61 1.44 212.73 27.10 / 68.00
BLISS GVS PHARMA LTD 154.90 14.94 1.44 1637.64 105.05 / 190.65
CIPLA LTD 1508.10 22.39 3.70 121819.98 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 269.45 7.08 2.02 793.02 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.76 22.57 3.86 212.73 27.10 / 68.00
AMRUTAJAN HEALTH LTD 666.00 33.96 5.62 1925.45 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9089.00 98.29 28.43 22722.50 6301.00 / 10653.05
BLISS GVS PHARMA LTD 154.90 20.90 1.48 1637.64 105.05 / 190.65

Rubicon Research Ltd shareholding pattern

Holding

20.09%
59.98%
9.37%
10.54%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Rubicon Research Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
624.30 -1.03 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 642.00
  • 26 Days 642.80
  • 10 Days 650.90
  • 50 Days 642.40
  • 12 Days 652.30
  • 100 Days 642.40
  • 20 Days 650.00
  • 200 Days 642.40
634.80 PIVOT

First Support

624.85

First Resistance

640.80

Second Support

618.85

Second Resistance

650.75

Third Support

608.90

Third Resistance

656.75

RSI

44.14

ADX

40.82

MACD

9.43

Williams % R

-98.37

Commodity Channel Index (CCI)

-67.09

Date

2025-12-03

Week

86027.00

Same Day

53955.00

Month

209673.00

1 Year

0.48

3 Year

0.45

Over 1 Month

-3.48%

down

Over 1 Year

0.00%

down

Over 3 Months

0.42%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Rubicon Research Ltd Corporate Actions

Rubicon Research Ltd Share Price

Rubicon Research Limited was incorporated on May 6, 1999, as a Private Limited Company under the name Rubicon Consultants Private Limited', issued by the RoC. Subsequently, the Company name was changed from Rubicon Consultants Private Limited' to Rubicon
Research Private Limited' consequent to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002. The Company's status converted from a Private Limited Company to a Public Limited Company, the name was changed from Rubicon Research Private Limited' to Rubicon Research Limited'. A fresh Certificate of Incorporation dated July 23, 2024 was issued by
the Registrar of Companies, Central Processing Centre, Manesar, Haryana consequent to Company's conversion into a Public Limited Company.

Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. The Company is driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets, particularly, the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.

The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016, the Company acquired majority stake by ECP III Pte Ltd. Further, it acquired majority stake by General Atlantic Singapore RR Pte. Ltd., from ECP III Pte. Ltd. in 2019. In 2021, the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In 2024, the Company acquired Validus, a New Jersey headquartered marketer of brand name formulation products in the US. Validus has two
brand name products in the CNS therapy area (Equetro and Marplan).

The Company is planning to raise money from public through IPO aggregating to Rs 1085 Crores, consisting Rs 500 Crore Fresh Issue Equity Shares and an Offer for Sale of Rs 585 Crore Equity Shares.

Parent organization Indian Private
NSE symbol RUBICON
Founded 1999
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Rubicon Research Ltd?

Answer Field

Rubicon Research Ltd share price is for NSE ₹ 622.15 & for BSE ₹ 624.70 as on Dec 04 2025 03:29 PM.

What is the Market Cap of Rubicon Research Ltd Share?

Answer Field

The market cap of Rubicon Research Ltd for NSE ₹ 9,462.86 & for BSE ₹ 9,501.64 as on Dec 04 2025 03:29 PM.

What is the 52 Week High and Low of Rubicon Research Ltd?

Answer Field

The 52 Week High and Low of Rubicon Research Ltd for NSE is ₹ 754.80 and ₹ 570.75 and for BSE is ₹ 887.95 and ₹ 571.00.

What is 1 year return for Rubicon Research Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Rubicon Research Ltd Share?

Answer Field

As on Dec 04 2025 03:29 PM the price-to-earnings (PE) ratio for Rubicon Research Ltd share is 62.05.

What is the PB ratio of Rubicon Research Ltd Share?

Answer Field

As on Dec 04 2025 03:29 PM, the price-to-book (PB) ratio for Rubicon Research Ltd share is 71.10.

How to Buy Rubicon Research Ltd Share?

Answer Field

You can trade in Rubicon Research Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rubicon Research Ltd Share on Bajaj Broking App?

Answer Field

To buy Rubicon Research Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rubicon Research Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59